Filing Details
- Accession Number:
- 0000899243-18-019720
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-10 18:13:07
- Reporting Period:
- 2018-07-06
- Accepted Time:
- 2018-07-10 18:13:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1629137 | Global Blood Therapeutics Inc. | GBT | Air Transportation, Scheduled (4512) | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1053466 | L Deval Patrick | C/O Global Blood Therapeutics, Inc. 171 Oyster Point Blvd, Suite 300 South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-07-06 | 15,000 | $28.45 | 15,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-07-06 | 15,000 | $20.00 | 30,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-07-06 | 8,361 | $20.00 | 38,361 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-07-06 | 4,018 | $3.40 | 42,379 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-07-06 | 42,379 | $43.40 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-07-06 | 15,000 | $0.00 | 15,000 | $28.45 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-07-06 | 15,000 | $0.00 | 15,000 | $20.00 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-07-06 | 8,361 | $0.00 | 8,361 | $20.00 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-07-06 | 4,018 | $0.00 | 4,018 | $3.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2027-06-19 | No | 4 | M | Direct | |
| 0 | 2025-08-10 | No | 4 | M | Direct | |
| 239 | 2025-08-20 | No | 4 | M | Direct | |
| 5,357 | 2025-04-08 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sale price of the shares sold ranging from $43.35 to $43.85 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- The shares subject to this option shall vest and become exercisable in 12 equal monthly installments with the first installment on July 20, 2017, subject to the recipient's continued service on the Issuer's Board of Directors, such that this option became fully exercisable on June 20, 2018. This option is subject to accelerated vesting upon a change of control of the Issuer.
- The shares subject to this option shall vest and become exercisable in 12 equal monthly installments with the first installment on September 11, 2015, such that this option became fully exercisable on August 11, 2016. This option is subject to accelerated vesting upon a change of control of the Issuer.
- The shares subject to this option shall vest and become exercisable in 36 equal monthly installments with the first installment on August 23, 2015, such that this option is fully exercisable on July 23, 2018. This option is subject to accelerated vesting upon a change of control of the Issuer.
- 25% of the shares subject to this option vested and became exercisable on April 8, 2016, and the remaining shares subject to this option shall vest and become exercisable in 12 equal quarterly installments thereafter.
Billionaire Hedge Funds
